North Carolina PFAS Settlement Spreads $455 Million Over 15 Years

Chemours, DuPont and Corteva have agreed to pay $455 million to North Carolina and 11 communities over PFAS contamination claims that sit outside their earlier $1.2 billion national public-water settlement. The number is legally important. It is not the amount that any one company will expense or pay in cash today.

Payments extend over 15 years. Chemours is responsible for half under the companies' PFAS cost-sharing framework and is expected to make a $50 million payment within the first year. DuPont had already established a $125 million pre-tax accrual for the North Carolina and municipal matters as of June 30, before the final agreement was announced.

Time alone materially changes the economic burden. The public reporting does not disclose the complete year-by-year $455 million payment schedule, so an exact present value cannot be reproduced. An illustrative sensitivity makes the effect visible: if the first $50 million were paid in year one and the remaining $405 million were spread evenly over years two through 15, the present value would be about $320 million at a 5% discount rate, $267 million at 8% and $239 million at 10%.

Those figures are not estimates of the legal liability. They assume a level schedule that may differ from the settlement. They show why a 15-year nominal headline should not be dropped directly into a free-cash-flow model as an immediate $455 million charge.

Qnity absorbs 44% of DuPont's North Carolina funding obligations

The legacy DuPont structure adds another layer. DuPont's second-quarter filing says 44% of its funding obligations for the North Carolina matters are contractually allocated to Qnity, which indemnifies DuPont for that share. The result is a separation among legal exposure, accounting expense and ultimate cash funding.

DuPont and Corteva are also expected to contribute to a $135 million reserve that can support obligations if Chemours does not meet its share. The reserve is credit support, not a prediction of default, but it prevents investors from treating the stated company allocation as an absolute ceiling under every scenario.

The settlement also does not end the wider PFAS portfolio. Remediation obligations continue, and other state, federal and private claims remain outside this claim set. What changes is measurability: an uncertain North Carolina litigation exposure becomes a defined nominal amount with long-dated cash payments and an existing contractual sharing framework.

For shareholders, the useful bridge is therefore narrower than $455 million. It is future cash paid by each company after existing accruals, indemnification, reserve mechanics, tax and insurance effects. The full annual payment schedule is the one disclosure that would materially improve that bridge because it would allow the nominal settlement to be discounted without an illustrative assumption.

Sources

Wall Street Journal - North Carolina PFAS settlement · DuPont - Q2 2026 Form 10-Q · Chemours - Q2 2026 Form 10-Q · Qnity - Q2 2026 Form 10-Q